Evidence map›Paper›PMID 38997255›Full record

ArticleCell death & disease2024

AXDND1 is required to balance spermatogonial commitment and for sperm tail formation in mice and humans.

Brendan J Houston, Joseph Nguyen, D Jo Merriner, Anne E O'Connor, Alexandra M Lopes, Liina Nagirnaja, Corinna Friedrich, Sabine Kliesch, Frank Tüttelmann, Kenneth I Aston and 4 more

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Brendan J HoustonSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia. brendan.houston@unimelb.edu.au.ORCID 0000-0002-1078-756X
Joseph NguyenSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
D Jo MerrinerSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Anne E O'ConnorSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Alexandra M LopesInstituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Liina NagirnajaDivision of Genetics, Oregon National Primate Research Center, Beaverton, OR, USA.
Corinna FriedrichCentre of Medical Genetics, Institute of Reproductive Genetics, University of Münster, Münster, Germany.
Sabine KlieschCentre of Reproductive Medicine and Andrology, University Hospital Münster, University of Münster, Münster, Germany.
Frank TüttelmannCentre of Medical Genetics, Institute of Reproductive Genetics, University of Münster, Münster, Germany.ORCID 0000-0003-2745-9965
Kenneth I AstonGenetics of Male Infertility Initiative (GEMINI) Consortium, Beaverton, OR, USA.
Donald F ConradDivision of Genetics, Oregon National Primate Research Center, Beaverton, OR, USA.
Robin M HobbsCentre for Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Jessica E M DunleavySchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Moira K O'BryanSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia. moira.obryan@unimelb.edu.au.ORCID 0000-0001-7298-4940

Funding

Project IIIP50HD096723 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Kyle Edwin Orwig · 2019 to 2026
$15.0M
GENOMICS OF SPERMATOGENIC IMPAIRMENTR01HD078641 · NICHD · WASHINGTON UNIVERSITY · PI Kenneth Ivan Aston, DONALD F. CONRAD · 2014 to 2026
$6.3M
Department of Health | National Health and Medical Research Council (NHMRC) APP1120356Deutsche Forschungsgemeinschaft (German Research Foundation) CRU326Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) R01HD078641NICHD NIH HHS P50 HD096723NICHD NIH HHS R01 HD078641
6 · The paper itself

Abstract

Dynein complexes are large, multi-unit assemblies involved in many biological processes via their critical roles in protein transport and axoneme motility. Using next-generation sequencing of infertile men presenting with low or no sperm in their ejaculates, we identified damaging variants in the dynein-related gene AXDND1. We thus hypothesised that AXDND1 is a critical regulator of male fertility. To test this hypothesis, we produced a knockout mouse model. Axdnd1

Indexed as

Mice, KnockoutSpermatogenesisSpermatogoniaSperm TailAnimalsAxonemal DyneinsCell DifferentiationDyneinsHumansInfertility, MaleMaleMiceMice, Inbred C57BLTestisAxonemal DyneinsDyneins

Identifiers

PMID38997255
PMCPMC11245616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.